自己資本利益率 (ROE)
2005年以降
計算
Amgen Inc.、 ROE、長期トレンド計算
| ROE | = | 100 | × | 手取り1 | ÷ | 株主資本1 | |
|---|---|---|---|---|---|---|---|
| 2023/12/31 | 107.78% | = | 100 | × | 6,717) | ÷ | 6,232) |
| 2022/12/31 | 178.97% | = | 100 | × | 6,552) | ÷ | 3,661) |
| 2021/12/31 | 87.96% | = | 100 | × | 5,893) | ÷ | 6,700) |
| 2020/12/31 | 77.20% | = | 100 | × | 7,264) | ÷ | 9,409) |
| 2019/12/31 | 81.07% | = | 100 | × | 7,842) | ÷ | 9,673) |
| 2018/12/31 | 67.15% | = | 100 | × | 8,394) | ÷ | 12,500) |
| 2017/12/31 | 7.84% | = | 100 | × | 1,979) | ÷ | 25,241) |
| 2016/12/31 | 25.85% | = | 100 | × | 7,722) | ÷ | 29,875) |
| 2015/12/31 | 24.71% | = | 100 | × | 6,939) | ÷ | 28,083) |
| 2014/12/31 | 20.01% | = | 100 | × | 5,158) | ÷ | 25,778) |
| 2013/12/31 | 23.00% | = | 100 | × | 5,081) | ÷ | 22,096) |
| 2012/12/31 | 22.80% | = | 100 | × | 4,345) | ÷ | 19,060) |
| 2011/12/31 | 19.35% | = | 100 | × | 3,683) | ÷ | 19,029) |
| 2010/12/31 | 19.32% | = | 100 | × | 4,627) | ÷ | 23,944) |
| 2009/12/31 | 20.32% | = | 100 | × | 4,605) | ÷ | 22,667) |
| 2008/12/31 | 20.58% | = | 100 | × | 4,196) | ÷ | 20,386) |
| 2007/12/31 | 17.72% | = | 100 | × | 3,166) | ÷ | 17,869) |
| 2006/12/31 | 15.56% | = | 100 | × | 2,950) | ÷ | 18,964) |
| 2005/12/31 | 17.96% | = | 100 | × | 3,674) | ÷ | 20,451) |
レポートに基づく: 10-K (報告日: 2023-12-31), 10-K (報告日: 2022-12-31), 10-K (報告日: 2021-12-31), 10-K (報告日: 2020-12-31), 10-K (報告日: 2019-12-31), 10-K (報告日: 2018-12-31), 10-K (報告日: 2017-12-31), 10-K (報告日: 2016-12-31), 10-K (報告日: 2015-12-31), 10-K (報告日: 2014-12-31), 10-K (報告日: 2013-12-31), 10-K (報告日: 2012-12-31), 10-K (報告日: 2011-12-31), 10-K (報告日: 2010-12-31), 10-K (報告日: 2009-12-31), 10-K (報告日: 2008-12-31), 10-K (報告日: 2007-12-31), 10-K (報告日: 2006-12-31), 10-K (報告日: 2005-12-31).
1 百万米ドル
競合他社との比較
Amgen Inc.、 ROE、長期トレンド、競合他社との比較
| Amgen Inc. | AbbVie Inc. | Bristol-Myers Squibb Co. | Danaher Corp. | Eli Lilly & Co. | Gilead Sciences Inc. | Johnson & Johnson | Merck & Co. Inc. | Pfizer Inc. | Regeneron Pharmaceuticals Inc. | Thermo Fisher Scientific Inc. | Vertex Pharmaceuticals Inc. | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023/12/31 | 107.78% | 46.94% | 27.27% | 8.91% | 48.65% | 24.81% | 51.11% | 0.97% | 2.38% | 15.22% | 12.83% | 20.59% |
| 2022/12/31 | 178.97% | 68.60% | 20.37% | 14.39% | 58.64% | 21.62% | 23.36% | 31.57% | 32.79% | 19.14% | 15.80% | 23.88% |
| 2021/12/31 | 87.96% | 74.91% | 19.46% | 14.24% | 62.16% | 29.55% | 28.20% | 34.17% | 28.47% | 43.03% | 18.94% | 23.19% |
| 2020/12/31 | 77.20% | 35.30% | -23.84% | 9.17% | 109.79% | 0.68% | 23.25% | 27.91% | 15.21% | 31.86% | 18.47% | 31.22% |
| 2019/12/31 | 81.07% | — | 6.66% | 9.94% | 319.09% | 23.91% | 25.42% | 37.99% | 25.77% | 19.08% | 12.45% | 19.34% |
| 2018/12/31 | 67.15% | — | 35.07% | 9.40% | 32.88% | 25.51% | 25.60% | 23.30% | 17.59% | 27.91% | 10.65% | 47.28% |
| 2017/12/31 | 7.84% | 104.16% | 8.58% | 9.45% | -1.76% | 22.64% | 2.16% | 6.97% | 29.47% | 19.51% | 8.76% | 12.99% |
| 2016/12/31 | 25.85% | 128.41% | 27.55% | 11.10% | 19.54% | 71.48% | 23.49% | 9.78% | 12.12% | 20.13% | 9.39% | -9.69% |
| 2015/12/31 | 24.71% | 130.39% | 10.97% | 14.17% | 16.53% | 97.70% | 21.66% | 9.94% | 10.75% | 17.40% | 9.25% | -59.19% |
| 2014/12/31 | 20.01% | 101.84% | 13.49% | 11.11% | 15.55% | 78.45% | 23.40% | 24.50% | 12.81% | 13.69% | 9.22% | -68.70% |
| 2013/12/31 | 23.00% | 91.90% | 16.91% | 12.04% | 26.57% | 27.05% | 18.68% | 8.85% | 28.83% | 21.74% | 7.55% | -32.81% |
| 2012/12/31 | 22.80% | 156.85% | 14.39% | 12.58% | 27.69% | 27.84% | 16.74% | 11.63% | 17.93% | 60.24% | 7.62% | -10.71% |
| 2011/12/31 | 19.35% | — | 23.25% | 12.85% | 32.11% | 41.60% | 16.94% | 11.50% | 12.18% | -45.65% | 8.84% | 3.76% |
| 2010/12/31 | 19.32% | — | 19.74% | 13.08% | 40.82% | 49.48% | 23.57% | 1.58% | 9.40% | -19.79% | 6.74% | -149.74% |
| 2009/12/31 | 20.32% | — | 71.49% | 9.90% | 45.45% | 41.40% | 24.25% | 21.85% | 9.59% | -17.10% | 5.51% | -58.57% |
| 2008/12/31 | 20.58% | — | 42.86% | 13.43% | -30.76% | 48.43% | 30.46% | 41.63% | 14.08% | -19.75% | 6.66% | -192.51% |
| 2007/12/31 | 17.72% | — | 20.50% | 15.08% | 21.61% | 46.69% | 24.41% | 18.01% | 12.53% | -22.94% | 5.25% | -144.23% |
| 2006/12/31 | 15.56% | — | 15.86% | 16.89% | 24.25% | -65.54% | 28.11% | 25.25% | 27.10% | -47.24% | 1.21% | -40.89% |
| 2005/12/31 | 17.96% | — | 26.77% | 17.67% | 18.34% | 26.88% | 27.49% | 25.85% | 12.32% | -83.72% | 7.99% | -85.05% |
レポートに基づく: 10-K (報告日: 2023-12-31), 10-K (報告日: 2022-12-31), 10-K (報告日: 2021-12-31), 10-K (報告日: 2020-12-31), 10-K (報告日: 2019-12-31), 10-K (報告日: 2018-12-31), 10-K (報告日: 2017-12-31), 10-K (報告日: 2016-12-31), 10-K (報告日: 2015-12-31), 10-K (報告日: 2014-12-31), 10-K (報告日: 2013-12-31), 10-K (報告日: 2012-12-31), 10-K (報告日: 2011-12-31), 10-K (報告日: 2010-12-31), 10-K (報告日: 2009-12-31), 10-K (報告日: 2008-12-31), 10-K (報告日: 2007-12-31), 10-K (報告日: 2006-12-31), 10-K (報告日: 2005-12-31).
産業部門との比較: 製薬、バイオテクノロジー、ライフサイエンス
Amgen Inc.、 ROE、長期トレンド、産業部門との比較: 製薬、バイオテクノロジー、ライフサイエンス
| Amgen Inc. | 製薬、バイオテクノロジー、ライフサイエンス | |
|---|---|---|
| 2023/12/31 | 107.78% | 20.65% |
| 2022/12/31 | 178.97% | 27.99% |
| 2021/12/31 | 87.96% | 29.75% |
| 2020/12/31 | 77.20% | 17.22% |
| 2019/12/31 | 81.07% | 27.68% |
| 2018/12/31 | 67.15% | 26.29% |
| 2017/12/31 | 7.84% | 14.59% |
| 2016/12/31 | 25.85% | 22.19% |
| 2015/12/31 | 24.71% | 21.44% |
| 2014/12/31 | 20.01% | 20.91% |
| 2013/12/31 | 23.00% | 20.33% |
| 2012/12/31 | 22.80% | 18.27% |
| 2011/12/31 | 19.35% | 15.52% |
| 2010/12/31 | 19.32% | 13.99% |
| 2009/12/31 | 20.32% | 20.34% |
| 2008/12/31 | 20.58% | 21.31% |
| 2007/12/31 | 17.72% | 17.07% |
| 2006/12/31 | 15.56% | 21.86% |
| 2005/12/31 | 17.96% | 19.08% |
レポートに基づく: 10-K (報告日: 2023-12-31), 10-K (報告日: 2022-12-31), 10-K (報告日: 2021-12-31), 10-K (報告日: 2020-12-31), 10-K (報告日: 2019-12-31), 10-K (報告日: 2018-12-31), 10-K (報告日: 2017-12-31), 10-K (報告日: 2016-12-31), 10-K (報告日: 2015-12-31), 10-K (報告日: 2014-12-31), 10-K (報告日: 2013-12-31), 10-K (報告日: 2012-12-31), 10-K (報告日: 2011-12-31), 10-K (報告日: 2010-12-31), 10-K (報告日: 2009-12-31), 10-K (報告日: 2008-12-31), 10-K (報告日: 2007-12-31), 10-K (報告日: 2006-12-31), 10-K (報告日: 2005-12-31).
業界との比較: 医療
Amgen Inc.、 ROE、長期トレンド、業界との比較: 医療
| Amgen Inc. | 医療 | |
|---|---|---|
| 2023/12/31 | 107.78% | 18.07% |
| 2022/12/31 | 178.97% | 22.47% |
| 2021/12/31 | 87.96% | 22.98% |
| 2020/12/31 | 77.20% | 16.02% |
| 2019/12/31 | 81.07% | 20.98% |
| 2018/12/31 | 67.15% | 17.71% |
| 2017/12/31 | 7.84% | 14.11% |
| 2016/12/31 | 25.85% | 18.09% |
| 2015/12/31 | 24.71% | 18.16% |
| 2014/12/31 | 20.01% | 18.60% |
| 2013/12/31 | 23.00% | 18.15% |
| 2012/12/31 | 22.80% | 17.49% |
| 2011/12/31 | 19.35% | 15.29% |
| 2010/12/31 | 19.32% | 14.41% |
| 2009/12/31 | 20.32% | 19.34% |
| 2008/12/31 | 20.58% | 18.87% |
| 2007/12/31 | 17.72% | 16.99% |
| 2006/12/31 | 15.56% | 20.34% |
| 2005/12/31 | 17.96% | 18.42% |
レポートに基づく: 10-K (報告日: 2023-12-31), 10-K (報告日: 2022-12-31), 10-K (報告日: 2021-12-31), 10-K (報告日: 2020-12-31), 10-K (報告日: 2019-12-31), 10-K (報告日: 2018-12-31), 10-K (報告日: 2017-12-31), 10-K (報告日: 2016-12-31), 10-K (報告日: 2015-12-31), 10-K (報告日: 2014-12-31), 10-K (報告日: 2013-12-31), 10-K (報告日: 2012-12-31), 10-K (報告日: 2011-12-31), 10-K (報告日: 2010-12-31), 10-K (報告日: 2009-12-31), 10-K (報告日: 2008-12-31), 10-K (報告日: 2007-12-31), 10-K (報告日: 2006-12-31), 10-K (報告日: 2005-12-31).